Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Fuhr

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
European Journal of Clinical Pharmacology|August 9, 2007
What is the true risk of a pharmacokinetic drug-drug interaction?Uwe Fuhr
Clinical Pharmacology and Therapeutics|July 30, 2017
Pharmacokinetic Phenotyping to Predict Drug-Drug Interactions: Time to Divorce the Hybrid Concept of Simultaneous Mechanistic-Based and Exposure-Based AssessmentUwe Fuhr
European Journal of Clinical Pharmacology|January 4, 2008
Improvement in the handling of drug-drug interactionsUwe Fuhr
Journal of Clinical Pharmacology|January 22, 2010
Pharmacogenetic-based clinical scores: a useful, simple tool to predict tamoxifen-based CYP2D6 phenotype?Uwe Fuhr
International Journal of Clinical Pharmacology and Therapeutics|May 1, 2012
Phenotyping the activity of drug metabolizing enzymes using limited sampling strategies: perturbations and biasUwe Fuhr
European Journal of Clinical Pharmacology|April 25, 2015
Channeling the flood of meta-analysesUwe Fuhr, Martin Hellmich
European Journal of Clinical Pharmacology|October 22, 2008
Influence of posture on pharmacokineticsChristian Queckenberg, Uwe Fuhr
Planta Medica|May 17, 2012
Phenotyping studies to assess the effects of phytopharmaceuticals on in vivo activity of main human cytochrome p450 enzymesGregor Zadoyan, Uwe Fuhr
Journal of Pharmaceutical Sciences|July 13, 2024
Understanding plasma protein binding of drugs: Considering complexity and binding dynamicsTobias Heinen, Uwe Fuhr
Clinical Pharmacokinetics|July 2, 2009
Clinical pharmacokinetics and pharmacodynamics of solifenacinOxana Doroshyenko, Uwe Fuhr
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Pharmacology|August 9, 2007
What is the true risk of a pharmacokinetic drug-drug interaction?Uwe Fuhr
Clinical Pharmacology and Therapeutics|July 30, 2017
Pharmacokinetic Phenotyping to Predict Drug-Drug Interactions: Time to Divorce the Hybrid Concept of Simultaneous Mechanistic-Based and Exposure-Based AssessmentUwe Fuhr
European Journal of Clinical Pharmacology|January 4, 2008
Improvement in the handling of drug-drug interactionsUwe Fuhr
Journal of Clinical Pharmacology|January 22, 2010
Pharmacogenetic-based clinical scores: a useful, simple tool to predict tamoxifen-based CYP2D6 phenotype?Uwe Fuhr
International Journal of Clinical Pharmacology and Therapeutics|May 1, 2012
Phenotyping the activity of drug metabolizing enzymes using limited sampling strategies: perturbations and biasUwe Fuhr
European Journal of Clinical Pharmacology|April 25, 2015
Channeling the flood of meta-analysesUwe Fuhr, Martin Hellmich
European Journal of Clinical Pharmacology|October 22, 2008
Influence of posture on pharmacokineticsChristian Queckenberg, Uwe Fuhr
Planta Medica|May 17, 2012
Phenotyping studies to assess the effects of phytopharmaceuticals on in vivo activity of main human cytochrome p450 enzymesGregor Zadoyan, Uwe Fuhr
Journal of Pharmaceutical Sciences|July 13, 2024
Understanding plasma protein binding of drugs: Considering complexity and binding dynamicsTobias Heinen, Uwe Fuhr
Clinical Pharmacokinetics|July 2, 2009
Clinical pharmacokinetics and pharmacodynamics of solifenacinOxana Doroshyenko, Uwe Fuhr
Pageof 14